Tango Therapeutics IncNASDAQ:TNGX
- LAST PRICE5.4350
- TODAY'S CHANGE (%)-0.2750 (-4.8161%)
- Bid / Lots5.1600/ 31
- Ask / Lots5.7000/ 2
- Open / Previous Close5.6400 / 5.7100
- Day Range
- 52 Week Range
- Volume522,013
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | TNGX |
|---|---|---|
| 09:32 ET | 3827 | 5.62 |
| 09:34 ET | 300 | 5.63 |
| 09:36 ET | 700 | 5.65 |
| 09:39 ET | 100 | 5.67 |
| 09:45 ET | 500 | 5.67 |
| 09:48 ET | 200 | 5.665 |
| 09:50 ET | 100 | 5.66 |
| 09:52 ET | 464 | 5.635 |
| 09:54 ET | 100 | 5.64 |
| 09:56 ET | 1335 | 5.57 |
| 09:57 ET | 300 | 5.58 |
| 09:59 ET | 882 | 5.59 |
| 10:03 ET | 929 | 5.6259 |
| 10:06 ET | 1200 | 5.6 |
| 10:08 ET | 480 | 5.61 |
| 10:12 ET | 200 | 5.6292 |
| 10:15 ET | 537 | 5.62 |
| 10:19 ET | 20989 | 5.66 |
| 10:21 ET | 325 | 5.655 |
| 10:24 ET | 100 | 5.655 |
| 10:26 ET | 701 | 5.65 |
| 10:28 ET | 462 | 5.64 |
| 10:30 ET | 2100 | 5.65 |
| 10:32 ET | 343 | 5.62 |
| 10:35 ET | 552 | 5.6 |
| 10:37 ET | 2078 | 5.61 |
| 10:39 ET | 100 | 5.62 |
| 10:42 ET | 200 | 5.63 |
| 10:44 ET | 400 | 5.61 |
| 10:46 ET | 450 | 5.61 |
| 10:50 ET | 848 | 5.605 |
| 10:53 ET | 100 | 5.6 |
| 10:57 ET | 626 | 5.63 |
| 11:00 ET | 200 | 5.64 |
| 11:04 ET | 1193 | 5.61 |
| 11:06 ET | 100 | 5.6 |
| 11:08 ET | 700 | 5.58 |
| 11:09 ET | 700 | 5.57 |
| 11:11 ET | 1300 | 5.57 |
| 11:13 ET | 700 | 5.55 |
| 11:15 ET | 700 | 5.56 |
| 11:18 ET | 600 | 5.54 |
| 11:20 ET | 1105 | 5.53 |
| 11:22 ET | 20778 | 5.6 |
| 11:24 ET | 311 | 5.605 |
| 11:26 ET | 600 | 5.62 |
| 11:27 ET | 200 | 5.6 |
| 11:29 ET | 600 | 5.595 |
| 11:31 ET | 400 | 5.59 |
| 11:33 ET | 700 | 5.58 |
| 11:36 ET | 1073 | 5.605 |
| 11:38 ET | 500 | 5.61 |
| 11:40 ET | 1913 | 5.59 |
| 11:42 ET | 400 | 5.56 |
| 11:44 ET | 3550 | 5.57 |
| 11:45 ET | 400 | 5.555 |
| 11:47 ET | 730 | 5.56 |
| 11:49 ET | 950 | 5.57 |
| 11:51 ET | 1000 | 5.56 |
| 11:54 ET | 250 | 5.55 |
| 11:56 ET | 1200 | 5.555 |
| 11:58 ET | 900 | 5.59 |
| 12:00 ET | 100 | 5.59 |
| 12:02 ET | 1016 | 5.6 |
| 12:03 ET | 800 | 5.6 |
| 12:05 ET | 600 | 5.61 |
| 12:07 ET | 4759 | 5.62 |
| 12:09 ET | 4300 | 5.615 |
| 12:14 ET | 300 | 5.62 |
| 12:16 ET | 1000 | 5.615 |
| 12:18 ET | 658 | 5.61 |
| 12:20 ET | 1600 | 5.62 |
| 12:21 ET | 1564 | 5.64 |
| 12:25 ET | 450 | 5.65 |
| 12:27 ET | 1385 | 5.64 |
| 12:30 ET | 200 | 5.63 |
| 12:32 ET | 500 | 5.63 |
| 12:34 ET | 400 | 5.63 |
| 12:36 ET | 200 | 5.63 |
| 12:38 ET | 1200 | 5.59 |
| 12:39 ET | 799 | 5.58 |
| 12:41 ET | 600 | 5.57 |
| 12:43 ET | 200 | 5.57 |
| 12:45 ET | 300 | 5.58 |
| 12:48 ET | 500 | 5.57 |
| 12:50 ET | 500 | 5.55 |
| 12:52 ET | 600 | 5.54 |
| 12:54 ET | 1000 | 5.55 |
| 12:56 ET | 400 | 5.55 |
| 12:57 ET | 200 | 5.55 |
| 12:59 ET | 500 | 5.55 |
| 01:01 ET | 1214 | 5.565 |
| 01:06 ET | 100 | 5.565 |
| 01:08 ET | 1767 | 5.535 |
| 01:10 ET | 7648 | 5.5 |
| 01:12 ET | 700 | 5.49 |
| 01:14 ET | 1111 | 5.48 |
| 01:15 ET | 500 | 5.48 |
| 01:17 ET | 2765 | 5.5 |
| 01:19 ET | 5077 | 5.49 |
| 01:21 ET | 1352 | 5.49 |
| 01:24 ET | 6631 | 5.53 |
| 01:26 ET | 6034 | 5.53 |
| 01:28 ET | 800 | 5.52 |
| 01:30 ET | 2000 | 5.51 |
| 01:32 ET | 700 | 5.51 |
| 01:33 ET | 600 | 5.5 |
| 01:35 ET | 1600 | 5.515 |
| 01:37 ET | 2050 | 5.51 |
| 01:39 ET | 742 | 5.52 |
| 01:42 ET | 2655 | 5.54 |
| 01:44 ET | 1111 | 5.52 |
| 01:46 ET | 4765 | 5.5 |
| 01:48 ET | 6162 | 5.501 |
| 01:50 ET | 16138 | 5.5 |
| 01:51 ET | 1200 | 5.51 |
| 01:53 ET | 1000 | 5.52 |
| 01:55 ET | 1598 | 5.54 |
| 01:57 ET | 1128 | 5.52 |
| 02:00 ET | 1349 | 5.52 |
| 02:02 ET | 4765 | 5.52 |
| 02:04 ET | 1944 | 5.51 |
| 02:06 ET | 2988 | 5.52 |
| 02:08 ET | 4583 | 5.5305 |
| 02:09 ET | 905 | 5.56 |
| 02:11 ET | 2000 | 5.565 |
| 02:13 ET | 870 | 5.555 |
| 02:15 ET | 975 | 5.535 |
| 02:18 ET | 700 | 5.535 |
| 02:20 ET | 1300 | 5.52 |
| 02:22 ET | 3026 | 5.53 |
| 02:24 ET | 1916 | 5.53 |
| 02:26 ET | 300 | 5.53 |
| 02:27 ET | 596 | 5.53 |
| 02:29 ET | 700 | 5.53 |
| 02:31 ET | 400 | 5.52 |
| 02:33 ET | 1690 | 5.525 |
| 02:36 ET | 600 | 5.51 |
| 02:38 ET | 1000 | 5.52 |
| 02:40 ET | 5201 | 5.51 |
| 02:42 ET | 1858 | 5.51 |
| 02:44 ET | 1045 | 5.515 |
| 02:45 ET | 800 | 5.52 |
| 02:47 ET | 600 | 5.51 |
| 02:49 ET | 400 | 5.51 |
| 02:51 ET | 3190 | 5.49 |
| 02:54 ET | 400 | 5.48 |
| 02:56 ET | 2537 | 5.5 |
| 02:58 ET | 2590 | 5.5 |
| 03:00 ET | 16188 | 5.52 |
| 03:02 ET | 1267 | 5.5 |
| 03:03 ET | 486 | 5.5 |
| 03:05 ET | 327 | 5.5 |
| 03:07 ET | 2040 | 5.491 |
| 03:09 ET | 1100 | 5.5 |
| 03:12 ET | 600 | 5.49 |
| 03:14 ET | 741 | 5.49 |
| 03:16 ET | 500 | 5.48 |
| 03:18 ET | 1705 | 5.495 |
| 03:20 ET | 7960 | 5.5 |
| 03:21 ET | 791 | 5.4901 |
| 03:23 ET | 3597 | 5.495 |
| 03:25 ET | 500 | 5.49 |
| 03:30 ET | 4579 | 5.485 |
| 03:32 ET | 300 | 5.495 |
| 03:34 ET | 700 | 5.495 |
| 03:36 ET | 2630 | 5.495 |
| 03:38 ET | 900 | 5.495 |
| 03:39 ET | 1756 | 5.49 |
| 03:41 ET | 1302 | 5.485 |
| 03:43 ET | 848 | 5.485 |
| 03:45 ET | 4248 | 5.48 |
| 03:48 ET | 3027 | 5.47 |
| 03:50 ET | 900 | 5.47 |
| 03:52 ET | 4759 | 5.4702 |
| 03:54 ET | 11492 | 5.46 |
| 03:56 ET | 9179 | 5.45 |
| 03:57 ET | 1534 | 5.465 |
| 03:59 ET | 99233 | 5.435 |
Oct 28, 2024
DJ Tango Therapeutics Price Target Maintained With a $13.00/Share by HC Wainwright & Co., from 8:20AM ET on Monday Oct 28, 2024 by Dow Jones
8:20AM ET on Monday Oct 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Tango Therapeutics Inc | 611.8M | -4.9x | --- |
OmniAb Inc | 471.5M | -6.6x | --- |
Cartesian Therapeutics Inc | 505.1M | -0.5x | --- |
AnaptysBio Inc | 669.5M | -3.4x | --- |
Foghorn Therapeutics Inc. | 444.8M | -3.9x | --- |
Kezar Life Sciences Inc | 597.6M | -0.5x | --- |
Company Information
Tango Therapeutics, Inc. is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering precision medicine for the treatment of cancer. The Company leverages the genetic principle of synthetic lethality to discover and develop therapies that take aim at critical targets in cancer. This includes expanding the universe of precision oncology targets into novel areas such as tumor suppressor gene loss and their contribution to the ability of cancer cells to evade immune cell killing. Its lead program, TNG908, is an methylthioadenosine (MTA)-cooperative inhibitor of protein arginine methyltransferase 5 (PRMT5) designed to work selectively in cancer cells with an methylthioadenosine phosphorylase (MTAP) deletion. Its TNG260 is a first-in-class Co-repressor of Repressor Element-1 Silencing Transcription (CoREST) inhibitor. The Company's programs also include TNG348 and TNG462. TNG348 is an allosteric inhibitor of ubiquitin-specific protease (USP1).
Contact Information
- Headquarters
- 201 Brookline Avenue, Suite 901BOSTON, MA, United States 02215
- Phone
- 857-320-4900
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Alexis Borisy
- President, Chief Executive Officer, Director
- Barbara Weber
- Chief Financial Officer
- Daniella Beckman
- President - Research and Development
- Adam Crystal
- Chief Human Resource Officer
- Julie Carretero
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $611.8M |
|---|---|
Revenue (TTM) | $42.5M |
Shares Outstanding | 107.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.83 |
EPS | $-1.11 |
Book Value | $2.48 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | 14.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -311.57% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
